Ausgabe 4/2011
Inhalt (14 Artikel)
Gender aspects in haematology and oncology: Overview and own observations in lung cancer
M. Fiegl, C. Thöni, M. Hochleitner
Gender differences in quality of life in patients with haematological malignancies
M. Sztankay, J. Giesinger, B. Holzner
Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics
R. M. Mader, M. Fiegl
Cancer in the elderly and gender aspects – situation in Tyrol
S. Geiger-Gritsch, H. Mühlböck, L. Harrasser, W. Oberaigner
Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway
W. Berger, A. Pircher, M. Sibilia, L. Bubendorf, M. Filipits, M. Fiegl, M. Früh, C. Manegold, H. Popper, W. Hilbe
A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*
H. Popper, F. Wrba, U. Gruber-Mösenbacher, W. Hulla, R. Pirker, W. Hilbe, M. Studnicka, A. Mohn-Staudner, F. Ploner
Surgical topics of interest at the 14th World Conference on Lung Cancer
F. Augustin, J. Bodner
The role of radiochemotherapy in the multimodal treatment of pancreatic ductal adenocarcinoma: Standard procedure or individual decision?
R. Jäger, A. de Vries
Treatment of invasive aspergillosis in cancer patients
J. Auberger, G. Russ, R. Greil, A. Egle